Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice

Laboratory Investigation

Volumn 74, Issue 2, 1996, Pages 363-373

  Perez Stable, Carlos ^a,b   Altman, Norman H ^a,b   Brown, John ^a   Harbison, Margaret ^c,d   Cray, Carolyn ^a,b   Roos, Bernard A ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c Columbia University ^*  (United States)

^d Hoffmann La Roche Department of Toxicology and Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBIN; VIRUS T ANTIGEN;

ADRENAL CORTEX TUMOR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CARCINOGENESIS; CHOROID PLEXUS TUMOR; EMBRYONAL TISSUE; GENE EXPRESSION; GENETIC TRANSFECTION; HYBRID GENE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ADRENAL CORTEX NEOPLASMS; ANDROGENS; ANIMALS; ANTIGENS, VIRAL, TUMOR; DNA, NEOPLASM; FEMALE; FETAL HEMOGLOBIN; LIPOMA; MALE; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RNA; TUMOR CELLS, CULTURED;

EID: 0030071527     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adams JM and Cory S (1991). Transgenic models of tumor development. Science (Washington) 54:1161-1167.
2. Aprikian AG, Cordon-Cardo C, Fair WR, and Reuter VE (1993). Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 71:3952-3965.
3. Auffray C and Rougeon F (1980). Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor DNA. Eur J Biochem 107:303-314.
4. Bang Y-J, Pirnia F, Fang W-G, Kang WK, Sartor O, Whitesell L, et al (1994). Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 91:5330-5334.
5. Behringer RR, Peschon JJ, Messing A, Gartside CL, Hauschka SD, Palmiter RD, and Brinster RL (1988). Heart and bone tumors in transgenic mice. Proc Natl Acad Sci USA 85:2648-2652.
6. Botteri FM, Putten H, Wong DF, Sauvage CA, and Evans RM (1987). Unexpected thymic hyperplasia in transgenic mice harboring a neuronal promoter fused with simian virus 40 large T antigen. Mol Cell Biol 7:3178-3184.
7. Brandes D, Kirchheim D, and Scott WW (1964). Ultrastructure of the human prostate: Normal and neoplastic. Lab Invest 13:1541-1560.
8. Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, and Palmiter RD (1984). Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37:367-379.
9. Brown JB, Carballeira A, and Fishman LM (1988). Rapid two-dimensional thin-layer chromatographic system for the separation of multiple steroids of secretory and neuroendocrine interest. J Chromatogr 439:441-447.
10. Casteilla L, Forest C, Robelin J, Ricquier D, Lombet A, and Ailhaud G (1987). Characterization of mitochondrial-uncoupling protein in bovine fetus and newborn calf. Am J Physiol 252:E627-E636.
11. Chada K, Magram J, and Costantini F (1986). An embryonic pattern of expression of a human fetal globin gene in transgenic mice. Nature (London) 319:685-689.
12. Chen TR (1993). Chromosomal identity of human prostate cancer cell lines, PC-3 and PPC-1. Cytogenet Cell Genet 62:183-184.
13. De Lellis RA (1989). The endocrine system. In: Pathologic basis of disease. Cotran RS, Kumar V, and Robbins SL, editors. Philadelphia: WB Saunders, 1205-1276.
14. Sant'Agnese PA (1992). Neuroendocrine differentiation in carcinoma of the prostate. Cancer Suppl 70:254-268.
15. Field LJ (1988). Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science (Washington) 239:1029-1033.
16. Fox N, Crooke R, Hwang LS, Schibler U, Knowles BB, and Solter D (1989). Metastatic hibernomas in transgenic mice expressing an α-amylase-SV40 T antigen hybrid gene. Science (Washington) 244:460-463.
17. Gkonos PJ, Krongrad A, and Roos BA (1995). Neuroendocrine peptides in the prostate. Urol Res 23:81-87.
18. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, et al (1995). Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439-3443.
19. Gumucio DL, Rood KL, Gray TA, Riordan MF, Sartor CI, and Collins FS (1988). Nuclear proteins that bind the human γ-globin gene promoter: Alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol 8:5310-5322.
20. Gumucio DL, Rood KL, Blanchard-McQuate KL, Gray TA, Saulino A, and Collins FS (1991). Interaction of Sp1 with the human γ-globin promoter: Binding and transactivation of normal and mutant promoters. Blood 78:1853-1863.
21. Hanahan D (1985). Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/ simian virus 40 oncogenes. Nature (London) 315:115-122.
22. Held WA, Mullins JJ, Kuhn N, Gallagher JF, Gu GD, and Gross KW (1989). T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/ SV40 T antigen hybrid gene. EMBO J 8:183-191.
23. Hogan BL, Costantini F, and Lacy E (1986). Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
24. Horoszewicz J, Leong S, Kawinski E, Kerr J, Rosenthal H, Chu T, et al (1983). LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818.
25. Idelman S (1970). Ultrastructure of the mammalian adrenal cortex. Int Rev Cytol 27:181-281.
26. Jacobsson A, Stadler U, Glotzer MA, and Kozak LP (1985). Mitochondrial uncoupling protein from mouse brown fat. J Biol Chem 260:16250-16254.
27. Jelbart ME, Russell PJ, Russell P, Wass J, Fullerton M, Wills EJ, and Raghavan D (1989). Site-specific growth of the prostate xenograft line UCRU-PR-2. Prostate 14:163-175.
28. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, and Jones LW (1979). Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23.
29. Kollias G, Wrighton N, Hurst J, and Grosveld F (1986). Regulated expression of human Aγ-, β-, and hybrid γ/β-globin genes in transgenic mice: Manipulation of the developmental expression patterns. Cell 46:89-94.
30. Kozak UC, Held W, Kreutter D, and Kozak LP (1992). Adrenergic regulation of the mitochondrial uncoupling protein gene in brown fat tumor cells. Mol Endocrinol 6:763-772.
31. Krongrad A, Allman DR, Brothman AR, and McPhaul MJ (1991). The expression of the human androgen receptor (AR) in an androgen unresponsive human prostate cancer cell line (PPC-1) is insufficient to confer androgen responsiveness (abstract). J Urol 145:295A.
32. Mahon KA, Chepelinsky AB, Khillan JS, Overbeek PA, Piatigorsky J, and Westphal H (1988). Oncogenesis of the lens in transgenic mice. Science (Washington) 235:1622-1628.
33. Maroulakou IG, Anver M, Garrett L, and Green JE (1994). Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 91:11236-11240.
34. Mellon SH, Miller WL, Bair SR, Moore CCD, Vigne JL, and Weiner RI (1994). Steroidogenic adrenocortical cell lines produced by genetically targeted tumorigenesis in transgenic mice. Mol Endocrinol 8:97-108.
35. Mostofi F, Davis CJ, and Sesterhenn IA (1992). Pathology of carcinoma of the prostate. Cancer 70:235-253.
36. Nedergaard JE, Connolly E, and Cannon B (1986). Brown adipose tissue in the mammalian neonate. In: Brown adipose tissue. Trayhurn P and Nicholls DG, editors. London: Arnold, 153-213.
37. Ornitz DM, Hammer RE, Messing A, Palmiter RD, and Brinster RL (1987). Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science (Washington) 238:188-193.
38. Perez-Stable C (1994). Distinct negative regulatory mechanisms involved in the repression of human embryonic ∈- and fetal Gγ-globin genes in transgenic mice. J Biol Chem 269:33109-33115.
39. Perez-Stable C and Costantini F (1990). Roles of fetal Gγ-globin promoter elements and the adult β-globin 3′ enhancer in the stage-specific expression of globin genes. Mol Cell Biol 10:1116-1125.
40. Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, et al (1993). Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7:23-36.
41. Reynolds RK, Hoekzema GS, Vogel J, Hinrichs SH, and Jay G (1988). Multiple endocrine neoplasia induced by the promiscuous expression of a viral oncogene. Proc Natl Acad Sci USA 85:3135-3139.
42. Rogler LE and Pintar JE (1993). Expression of the P450 side-chain cleavage and adrenodoxin genes begins during early stages of adrenal cortex development. Mol Endocrinol 7:453-461.
43. Ross SR, Choy L, Graves RA, Fox N, Solevjeva V, Klaus S, et al (1992). Hibernoma formation in transgenic mice and isolation of a brown adipocyte cell line expressing the uncoupling protein gene. Proc Natl Acad Sci USA 89:7561-7565.
44. Schultz P, Stucka R, Feldman H, Combriato G, Klobeck H-G, and Fittler F (1988). Sequence of a cDNA encompassing the complete mature human prostate specific antigen (PSA) and an unspliced leader sequence. Nucl Acids Res 16:6226.
45. Simpson ER and Waterman MR (1992). Regulation of expression of adrenocortical enzymes. In: Comprehensive endocrinology: The adrenal gland. James VH, editor. New York: Raven Press, 191-207.
46. Skalnik DG, Dorfman DM, Perkins AS, Jenkins NA, Copeland NG, and Orkin SH (1991a). Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc Natl Acad Sci USA 88:8505-8509.
47. Skalnik DG, Dorfman DM, Williams DA, and Orkin SH (1991b). Restriction of neuroblastoma to the prostate gland in transgenic mice. Mol Cell Biol 11:4518-4527.
48. Stone KR, Mickey DD, Wunderli H, Mickey GH, and Paulson DF (1978). Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 21:274-281.
49. Swanson LW, Simmons DM, Arriza J, Hammer R, Brinster RL, Rosenfeld MG, and Evans RM (1985). Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes. Nature (London) 317:363-366.
50. Teitz T, Chang JC, Kitamura M, Yen TSB, and Kan YW (1993). Rhabdomyosarcoma arising in transgenic mice harboring the β-globin locus control region fused with simian virus 40 large T antigen gene. Proc Natl Acad Sci USA 90:2910-2914.
51. Teitz T, Yen TSB, Chang JC, and Kan YW (1994). SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice. DNA Cell Biol 7:705-710.
52. Trudel M, Magram J, Bruckner L, and Costantini F (1987). Upstream Gγ-globin and downstream β-globin sequences required for stage-specific expression in transgenic mice. Mol Cell Biol 7:4024-4029.
53. Wikenheiser KA, Clark JC, Linnoila RI, Stahlman MT, and Whitsett JA (1992). Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein c gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res 52:5342-5352.
54. Windle JJ, Albert DM, O'Brien JM, Marcus DM, Disteche CM, Bernards R, and Mellon PL (1990a). Retinoblastoma in transgenic mice. Nature (London) 343:665-669.
55. Windle JJ, Weiner RI, and Mellon PL (1990b). Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 4:597-603.
56. Yasumura Y, Buonassisi V, and Sato G (1966). Clonal analysis of differentiated function in animal cell cultures. Cancer Res 26:529-535.